{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:16:33Z","timestamp":1785550593991,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009863","name":"Neuroendocrine Tumor Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-CA54174"],"award-info":[{"award-number":["P30-CA54174"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["RP190043"],"award-info":[{"award-number":["RP190043"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["GM114102"],"award-info":[{"award-number":["GM114102"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.xcrm.2022.100686","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T11:03:39Z","timestamp":1658228619000},"page":"100686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions"],"prefix":"10.1016","volume":"3","author":[{"given":"Cynthia M.","family":"Estrada-Zuniga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purushoth","family":"Ethiraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Gonzalez-Cant\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaina","family":"Adderley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany N.","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Zainal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Aronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo C.T.","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-370X","authenticated-orcid":false,"given":"Patricia L.M.","family":"Dahia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2022.100686_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrc3680","article-title":"RET revisited: expanding the oncogenic portfolio","volume":"14","author":"Mulligan","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2022.100686_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2022.100686_bib3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/genes11040424","article-title":"RET gene fusions in malignancies of the thyroid and other tissues","volume":"11","author":"Santoro","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.xcrm.2022.100686_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0092-8674(90)90659-3","article-title":"PTC is a novel rearranged form of the ret proto-oncogene and is frequently expressed in\u00a0vivo in human papillary thyroid carcinomas","volume":"60","author":"Grieco","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100686_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nm.2644","article-title":"KIF5B-RET fusions in lung adenocarcinoma","volume":"18","author":"Kohno","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2022.100686_bib6","first-page":"100037","article-title":"Catalog of 5\u2032 fusion partners in RET+ NSCLC Circa 2020","volume":"1","author":"Ou","year":"2020","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.xcrm.2022.100686_bib7","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.trecan.2021.07.003","article-title":"Precision therapy for RET-altered cancers with RET inhibitors","volume":"12","author":"Thein","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2022.100686_bib8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1158\/2159-8290.CD-18-0338","article-title":"Precision targeted therapy with BLU-667 for RET-driven cancers","volume":"8","author":"Subbiah","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2022.100686_bib9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of selpercatinib in RET-altered thyroid cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100686_bib10","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/PO.21.00127","article-title":"Novel RET fusion RET-SEPTIN9 predicts response to selective RET inhibition with selpercatinib in malignant pheochromocytoma","volume":"5","author":"Mweempwa","year":"2021","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.xcrm.2022.100686_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2022.100686_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/humu.22170","article-title":"Multiple functional effects of RET kinase domain sequence variants in hirschsprung disease","volume":"34","author":"Hyndman","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.xcrm.2022.100686_bib13","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1242\/jcs.203885","article-title":"Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalization","volume":"130","author":"Hyndman","year":"2017","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.xcrm.2022.100686_bib14","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/MCB.15.3.1613","article-title":"Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations","volume":"15","author":"Asai","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2022.100686_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CCO.0b013e328011a25f","article-title":"Ba\/F3 cells and their use in kinase drug discovery","volume":"19","author":"Warmuth","year":"2007","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.xcrm.2022.100686_bib16","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1128\/MCB.01446-14","article-title":"MicroRNA 155 control of p53 activity is context dependent and mediated by Aicda and Socs1","volume":"35","author":"Bouamar","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2022.100686_bib17","doi-asserted-by":"crossref","first-page":"13442","DOI":"10.1074\/jbc.M500507200","article-title":"Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase","volume":"280","author":"Scott","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2022.100686_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.annonc.2020.10.599","article-title":"Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations","volume":"32","author":"Subbiah","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2022.100686_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.annonc.2021.02.010","article-title":"Patient-driven discovery and post-clinical validation of NTRK3 fusion as an acquired resistance mechanism to selpercatinib in RET fusion-positive lung cancer","volume":"32","author":"Subbiah","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2022.100686_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ccell.2017.01.009","article-title":"Pheochromocytomas and paragangliomas, genetically diverse and minimalist, all at once","volume":"31","author":"Dahia","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2022.100686_bib21","doi-asserted-by":"crossref","first-page":"39159","DOI":"10.1074\/jbc.M006908200","article-title":"Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-ret receptor tyrosine kinase","volume":"275","author":"Besset","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2022.100686_bib22","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.onc.1202046","article-title":"Grb2 binding to the different isoforms of Ret tyrosine kinase","volume":"17","author":"Alberti","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2022.100686_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.celrep.2018.03.050","article-title":"Driver fusions and their implications in the development and treatment of human cancers","volume":"23","author":"Gao","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2022.100686_bib24","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1158\/1078-0432.CCR-20-3208","article-title":"A performance comparison of commonly used assays to detect RET fusions","volume":"27","author":"Yang","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2022.100686_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41698-021-00221-z","article-title":"Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions","volume":"5","author":"Li","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.xcrm.2022.100686_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2022.100686_bib27","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1093\/bioinformatics\/btac166","article-title":"Analysing high-throughput sequencing data in Python with HTSeq 2.0","volume":"38","author":"Putri","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2022.100686_bib28","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2022.100686_bib29","first-page":"36","article-title":"Image processing with ImageJ","volume":"11","author":"Abr\u00e0moff","year":"2004","journal-title":"Biophot. Int."},{"key":"10.1016\/j.xcrm.2022.100686_bib30","doi-asserted-by":"crossref","first-page":"e3156","DOI":"10.1210\/clinem\/dgaa396","article-title":"Functional characterization of TMEM127 variants reveals novel insights into its membrane topology and trafficking","volume":"105","author":"Flores","year":"2020","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2022.100686_bib31","article-title":"STAR-fusion: fast and accurate fusion transcript detection from RNA-seq","author":"Haas","year":"2017","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2022.100686_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.xcrm.2022.100686_bib33","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1038\/s41467-019-12661-0","article-title":"The tumor suppressor TMEM127 regulates insulin sensitivity in a tissue-specific manner","volume":"10","author":"Srikantan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100686_bib34","doi-asserted-by":"crossref","first-page":"lqaa078","DOI":"10.1093\/nargab\/lqaa078","article-title":"ComBat-seq: batch effect adjustment for RNA-seq count data","volume":"2","author":"Zhang","year":"2020","journal-title":"NAR Genom. Bioinform."},{"key":"10.1016\/j.xcrm.2022.100686_bib35","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","article-title":"A scaling normalization method for differential expression analysis of RNA-seq data","volume":"11","author":"Robinson","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2022.100686_bib36","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1091\/mbc.e12-02-0114","article-title":"Alternative splicing results in RET isoforms with distinct trafficking properties","volume":"23","author":"Richardson","year":"2012","journal-title":"Mol. Biol. Cell"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122002221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122002221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:52:26Z","timestamp":1762987946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379122002221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2666379122002221"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100686","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742397678.793596420","asserted-by":"object"}]},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100686"}}